2295-58-1

基本信息
三羟苯丙酮
1-(2,4,6-三羟基苯基)丙-1-酮
2,4,6-TRIHYDROXYPROPIOPHENONE
FLOPROPIONE
PHLOPROPIOPHENONE
PHLOROPROPIOPHENONE
1-(2,4,6-trihydroxyphenyl)-1-propanon
1-(2,4,6-Trihydroxyphenyl)-1-propanone
13907 R. P.
13907r.p.
1-Propanone, 1-(2,4,6-trihydroxyphenyl)-
2’,4’,6’-trihydroxy-propiophenon
Argobyl
Chlonarin
Cospanon
Ecapron
Flopion
Flopropion
Gallepronin
Gasstenon
Labroda
物理化学性质
熔点 | 177°C |
沸点 | 275.56°C (rough estimate) |
密度 | 1.2481 (rough estimate) |
折射率 | 1.4500 (estimate) |
储存条件 | Inert atmosphere,Room Temperature |
溶解度 | 溶于二甲基亚砜 |
酸度系数(pKa) | 7.49±0.45(Predicted) |
形态 | 粉末晶体 |
颜色 | 白色至橙色再至绿色 |
Merck | 4106 |
LogP | 2.600 (est) |
CAS 数据库 | 2295-58-1(CAS DataBase Reference) |
NIST化学物质信息 | Flopropione(2295-58-1) |
EPA化学物质信息 | 1-Propanone, 1-(2,4,6-trihydroxyphenyl)- (2295-58-1) |
安全数据
危险性符号(GHS) | ![]() GHS07 |
警示词 | 警告 |
危险性描述 | H315-H319 |
防范说明 | P264-P280-P302+P352-P321-P332+P313-P362-P264-P280-P305+P351+P338-P337+P313P |
危险类别码 | R36/37/38 |
安全说明 | S26-S36/37/39 |
RTECS号 | UH4429100 |
海关编码 | 2914.50.3000 |
图谱信息
夫洛丙酮(2295-58-1)质谱(MS)夫洛丙酮(2295-58-1)核磁图(1HNMR)夫洛丙酮(2295-58-1)核磁图(13CNMR)夫洛丙酮(2295-58-1)红外图谱(IR1)夫洛丙酮(2295-58-1)红外图谱(IR2)夫洛丙酮价格(试剂级)
报价日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
2025/02/08 | HY-100562 | 夫洛丙酮 Flopropione | 2295-58-1 | 100mg | 350元 |
2025/02/08 | HY-100562 | 夫洛丙酮 Flopropione | 2295-58-1 | 10mM * 1mLin DMSO | 385元 |
2025/02/05 | T0887 | 2',4',6'-三羟基苯丙酮 2',4',6'-Trihydroxypropiophenone | 2295-58-1 | 1G | 110元 |
常见问题列表
5-HT 1A Receptor
|
COMT
|
Flopropione在低于其T (g)温度下表现出无Lorentzian舒张。Flopropione在低于其T (g)温度下比Nifedipine具有更高的分子流动性。 Flopropione在整个温度范围表现出Arrhenius温度依赖性,推断高于T (g)时通过介电弛豫测量的tau(β)与低于T (g)时通过TAM/MDSC测量的tau(β)相一致。
The effect of Flopropione as an antispasmodic agent on the rate of passing a calculus from the urinary tract has been compared retrospectively with patients in whom passage was spontaneous. Flopropine has been shown, with statistical significance, to be superior to the control in cumulative passage rate after initiation of administration. Flopropine has been shown to exert a spasmolytic effect not only on smooth muscle of the gastrointestinal tract but also on smooth muscle of the pancreatobiliary and urinary systems.